LMNB1 and central nervous system cancer: A study analyzing differently expressed genes of the 7 Gene Expression Omnibus (GEO) database by the Robust Rank Aggregation (RRA) method proposed LMNB1 as a potential biomarker for glioma, as patients with high expression of LMNB1 had lower survival rates, while silencing of LMNB1 inhibited the proliferation of glioma cells [45].